Quantitative Structure – Pharmacokinetics Relationships for Plasma Protein Binding of Basic Drugs

Quantitative Structure – Pharmacokinetics Relationships for Plasma Protein Binding of Basic Drugs

Purpose. Binding of drugs to plasma proteins is a common physiological occurrence which may have a profound effect on both pharmacokinetics and pharmacodynamics. The early prediction of plasma protein binding (PPB) of new drug candidates is an important step in drug development process. The present...

Full description

Bibliographic Details
Main Author:	Zvetanka Dobreva Zhivkova
Format:	Article
Language:	English
Published:	Canadian Society for Pharmaceutical Sciences 2018-01-01
Series:	Journal of Pharmacy & Pharmaceutical Sciences
Online Access:	https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/28971

Similar Items

Quantitative Structure – Pharmacokinetic Relationships for Plasma Clearance of Basic Drugs with Consideration of the Major Elimination Pathway
by: Zvetanka Dobreva Zhivkova
Published: (2017-05-01)

Quantitative Structure – Pharmacokinetics Relationships Analysis of Basic Drugs: Volume of Distribution
by: Zvetanka Dobreva Zhivkova, et al.
Published: (2015-10-01)

Pharmacokinetics, pharmacodynamics and protein binding of the anti-depresant drug mianserin
by: Shami, M. R.
Published: (1982)

Pharmacokinetics, Tissue Distribution, Excretion and Plasma Protein Binding Studies of Wogonin in Rats
by: Amer Talbi, et al.
Published: (2014-04-01)

Pharmacokinetics of some β-adrenoceptor antagonists : influence of age and altered plasma protein binding
by: Rigby, James Walter
Published: (1983)

Studies on the binding of drugs to uraemic plasma proteins
by: Mustapha, M. S.
Published: (1976)

Pharmacokinetics, urinary excretion and plasma protein binding of ofloxacin in water buffalo calves (Bubalus bubalis)
by: Ajay K. Ola, et al.
Published: (2013-04-01)

Identification and functional characterization of the novel MAR-binding protein, SATB2
by: Dobreva, Gergana
Published: (2004)

Quantitative prediction of breast cancer resistant protein mediated drug‐drug interactions using physiologically‐based pharmacokinetic modeling
by: Chester Costales, et al.
Published: (2021-09-01)

Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors
by: Georgi Stavrakov, et al.
Published: (2020-07-01)

Quantitative protein binding analysis of highly hydrophobic drugs and endogenous substances
by: Kimura, Tomoko
Published: (2011)

Pharmacokinetics, urinary excretion and plasma protein binding of ofloxacin in water buffalo calves (<i>Bubalus bubalis</i>)
by: Ajay K. Ola, et al.
Published: (2013-04-01)

PREDICTION OF HUMAN SYSTEMIC, BIOLOGICALLY RELEVANT PHARMACOKINETIC (PK) PROPERTIES BASED ON QUANTITATIVE STRUCTURE PHARMACOKINETIC RELATIONSHIPS (QSPKR) AND INTERSPECIES PHARMACOKINETIC ALLOMETRIC SCALING (PK-AS)
by: Badri, Prajakta
Published: (2010)

Basic Pharmacokinetic Study on Propofol
by: Liau, Jiun-kai, et al.
Published: (1993)

The correlation of plasma protein binding and molecular properties of selected antifungal drugs
by: Odović Jadranka V., et al.
Published: (2020-01-01)

LCâMS/MS assay for the determination of natamycin in rabbit and human plasma: Application to a pharmacokinetics and protein binding study
by: Yashpal Singh Chhonker, et al.
Published: (2013-04-01)

RNA Bind-n-Seq: Quantitative Assessment of the Sequence and Structural Binding Specificity of RNA Binding Proteins
by: Lambert, Nicole, et al.
Published: (2017)

Quantitative structure-activity relationship, molecular docking, drug-likeness, and pharmacokinetic studies of some non-small cell lung cancer therapeutic agents
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-12-01)

Quantitative Structure-Activity Relationships for Organophosphates Binding to Trypsin and Chymotrypsin
by: Ruark, Christopher Daniel
Published: (2010)

Development of microanalytical system for investigation of chiral selective drug bindings of plasma proteins
by: Kuroda, Yukihiro
Published: (2011)

Quantitative estimation of cilnidipine and valsartan in rat plasma by RP-HPLC: its pharmacokinetic application
by: Ramanlal N. Kachave, et al.
Published: (2021-01-01)

A study of small molecule-protein interactions : with special reference to the plasma protein binding of drugs
by: Wilson, Alan George Ernest
Published: (1974)

Pharmacokinetic Interaction of Paeoniflorin and Sinomenine: Pharmacokinetic Parameters and Tissue Distribution Characteristics in Rats and Protein Binding Ability In Vitro
by: Zhong Qiu Liu, et al.
Published: (2005-01-01)

Plasma protein binding of noradrenaline
by: Smith, Nigel
Published: (1990)

Stereoselective HPLC analysis of mexiletine enantiomers : pharmacokinetics and protein binding in humans
by: Igwemezie, Linus Nnamdi
Published: (2010)

Contribution of baicalin on the plasma protein binding displacement and CYP3A activity inhibition to the pharmacokinetic changes of nifedipine in rats in vivo and in vitro.
by: Zhen-Yu Cheng, et al.
Published: (2014-01-01)

Pharmacokinetics of Fisetin and Structure-Activity Relationship for the Effect of Flavonoids on the Cyclosporine Pharmacokinetics
by: CHI-SHENG SHIA, et al.
Published: (2003)

Basic Pharmacokinetic Concepts and Some Clinical Applications
Published: (2015)

Drug partitioning between plasma and erythrocytes as a model of pharmacokinetic volume of distribution
by: Wilson, Joy.
Published: (2013)

Drug partitioning between plasma and erythrocytes as a model of pharmacokinetic volume of distribution
by: Wilson, Joy.
Published: (2013)

Quantitative structure activity relationship (QSAR) of platinum drugs.
Published: (2006)

Physicochemical characteristics of structurally determined metabolite-protein and drug-protein binding events with respect to binding specificity.
by: Paula eKorkuć, et al.
Published: (2015-09-01)

Quantitation of Apremilast in Beagle Dogs Plasma by UPLC-MS-MS and Its Application to Pharmacokinetic Studies
by: Wei Xiong, et al.
Published: (2021-01-01)

Quantitative determination of metaxalone in human plasma by LC-MS and its application in a pharmacokinetic study
by: Lanting Zhao, et al.
Published: (2016-10-01)

Evaluation of the Pharmacokinetic-Pharmacodynamic relationship, Metabolism and Plasma Protein Binding of the novel antitumor agent, 2-Methoxyestradiol (2ME2), following oral administration in patients with solid tumors.
by: Lakhani, Nehal Jagdish
Published: (2005)

Drug binding defect of uraemic plasma : Role of endogenous binding inhibitors
by: Bishop, K. A.
Published: (1983)

Horse plasma vitamin D-binding protein : isolation and structural investigation
by: Robinson, Robert Charles
Published: (2010)

Structure-Based methods for the prediction of pharmacokinetic properties of drugs
by: Manga, Na ngono
Published: (2007)

Drug Metabolism and Pharmacokinetics
Published: (2024)

Pharmacokinetics, Tissue Distribution, Plasma Protein Binding Studies of 10-Dehydroxyl-12-Demethoxy-Conophylline, a Novel Anti-Tumor Candidate, in Rats
by: Chengjun Jiang, et al.
Published: (2019-01-01)